Ikonisys S.A. (EPA:ALIKO)

France flag France · Delayed Price · Currency is EUR
1.560
-0.070 (-4.29%)
At close: Mar 5, 2026
8.33%
Market Cap 24.72M
Revenue (ttm) 1.47M
Net Income (ttm) -2.86M
Shares Out 15.84M
EPS (ttm) -0.20
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 11,509
Average Volume 21,621
Open 1.630
Previous Close 1.630
Day's Range 1.530 - 1.630
52-Week Range 1.280 - 1.840
Beta 0.72
RSI 47.30
Earnings Date Apr 30, 2026

About Ikonisys

Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the fluorescence microscopy solution. The company also provides oncoFISH bladder that allows scanning and analysis of cells from a voided urine sample; oncoFI... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2021
Employees 15
Stock Exchange Euronext Paris
Ticker Symbol ALIKO
Full Company Profile

Financial Performance

In 2024, Ikonisys's revenue was 1.01 million, an increase of 56.72% compared to the previous year's 645,173. Losses were -3.24 million, 42.9% more than in 2023.

Financial Statements

News

There is no news available yet.